Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Swedish American Life Science Summit Continues To Address Cutting Edge Issues: Global Aging Is Focus In 2013

HOT CHOCOLATE BLOG By Leslie Wolf-Creutzfeldt, Grayling

Swedish American Life Science Summit Continues to Address Cutting Edge Issues:

Global Aging is Focus in 2013

The Swedish-American Life Science Summit (SALSS) recently announced that its upcoming 9th Annual Summit in August 2013 will focus on The Global Aging Dilemma: New Frontiers in Aging. Leaders in life sciences from all over the world will meet in Stockholm to explore new life science technologies to enhance health span and decrease global healthcare delivery costs

I attended the SALSS meeting in August in Stockholm which focused on the increasing globalization of the life science and healthcare industry and the importance of cross-border collaborations. I was struck by the unique blend of cutting edge scientists, global health care investors, and Swedish executives and government officials who went out of their way to make us all fall in love with Sweden. We enjoyed wonderful food, boat rides and concerts, in addition to coming together to explore latest trends and opportunities in the life sciences field. Several specific topics were discussed in depth, most notably the soaring global problem of Diabetes; and how the Digital Revolution will ultimately transform the way we provide healthcare.

The increasingly important role of Asia in the Life Sciences field was also explored and there were more representatives from Asian countries than ever before. Dr. Tachi Yamada, former President of the Global Health Program at the Bill & Melinda Gates Foundation and currently the Chief Medical Officer and Board Member of Takeda Pharmaceuticals, Japan's largest pharma gave the keynote closing speech in which he emphasized the importance of collaboration in the life sciences. Dr. Anjiang Liu from Shanghai Fosun Pharmaceutical U.S. Group, said, "SALSS provided Fosun with an excellent introduction to Sweden's pharmaceutical industry. We met very impressive companies and are continuing discussions about collaboration and investments. SALSS is a unique gathering of scientists and leading life sciences executives which allows for conversation and meetings while also gaining an appreciation of Swedish culture and heritage."

SALSS's Chairman and Founder, Barbro C. Ehnbom, said, "SALSS 2012 was the most successful meeting in terms of attendance, investments and collaboration. Next year, the topic of aging will be explored. We will also host discussions about related issues like stem cell therapies, telomeres, DNA repair, genetic modifiers and lifestyle intervention. In our continuing efforts to make SALSS more global, our coverage and focus next year will include South America, in particular Brazil, as an important emerging life science market." The invitation only gathering will take place in Stockholm from August 21- 23, 2013.

SALSS continues to show that business and pleasure can combine with cutting edge life science discussions for the benefit of everyone. I strongly recommend a closer look at this unique forum. For more information go to: salss.com.



For more information, contact:

Sana Alajmovic, Project Manager, SALSS 2012
Email: sana@swedishamericanlifescience.com
Mobile: 076 006 57 58

Or

Leslie Wolf-Creutzfeldt

Managing Director, Grayling

646-284-9472

leslie.wolf-creutzfeldt@grayling.com

Swedish-American Life Science Summit
Swedish-American Life Science Summit (SALSS) 2012 is held for the eighth consecutive year in Stockholm. The aim is to stimulate the Life Science sector in Sweden, paving the way for new investments and establish Stockholm as an international leading innovation and research center. The intense and exclusive three-day program includes panel discussions and presentations of selected, successful and promising companies. Participants received a special invitation and the program is filled with some of the most highly recognized leaders in Life Science and Investments worldwide. For more information on SALSS, visit www.salss.com